Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
ICPT holding history
Intercept Pharmaceuticals, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ICPT overviewAll 13F holders of ICPTFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −120,000−100.0% | Sold out | Holders |
| Q3 2023 | 120,000 | $2.22M | <0.1% | +110,429+1,153.8% | Added | Holders |
| Q2 2023 | 9,571 | $105.9K | <0.1% | +5,808+154.3% | Added | Holders |
| Q1 2023 | 3,763 | $50.5K | <0.1% | −235−5.9% | Reduced | Holders |
| Q4 2022 | 3,998 | $49.5K | <0.1% | +3,998 | New | Holders |